Results 51 to 60 of about 31,289 (278)

Elsberg Syndrome: Sudden Cauda Equina Syndrome After Aseptic Meningitis

open access: yesAnnals of Internal Medicine: Clinical Cases
Elsberg syndrome is a rare neurologic syndrome of acute or subacute lumbosacral radiculitis and myelitis with cauda equina syndrome. Commonly associated with herpes simplex virus type 2 infection, either primary or reactivation, it can occur with other ...
Kinari Tomite   +2 more
doaj   +1 more source

Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review

open access: yesTherapeutic Advances in Drug Safety, 2021
Background: Along with the increasing use of immune checkpoint inhibitors comes a surge in immune-related toxicity. Here, we review the currently available data regarding neurological immune adverse events, and more specifically aseptic meningitis and ...
Laure Thouvenin   +4 more
doaj   +1 more source

Draf III in the Acute Phase of Pott's Puffy Tumor: A Scoping Review

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Background Pott's puffy tumor (PPT) is a rare but serious sequela of frontal sinusitis characterized by osteomyelitis of the frontal bone with subperiosteal abscess formation. Surgical management has traditionally been delayed until resolution of the acute infection.
Sahil Kakar   +8 more
wiley   +1 more source

Rheumatoid meningitis sine arthritis. [PDF]

open access: yes, 2018
Rheumatoid meningitis is a rare and very serious extra-articular manifestation of rheumatoid arthritis. We present a case of a 7()year-old female with no history of arthritis who developed stroke-like symptoms, seizures, psychosis and compulsive behavior.
Berk, Matthew   +3 more
core   +1 more source

The price of tumor control [PDF]

open access: yes, 2013
Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients.
Bergmann, Tanja   +35 more
core   +1 more source

Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease

open access: yesPediatric Rheumatology Online Journal, 2011
Background Aseptic meningitis is a serious adverse reaction to intravenous immunoglobulin (IVIG) therapy. We studied the clinical characteristics of patients with acute Kawasaki disease (KD) who developed IVIG-induced aseptic meningitis.
Matsuura Hiroyuki   +3 more
doaj   +1 more source

Aseptic meningitis as the initial presentation of Leptospira borgpetersenii serovar Tarassovi: two case reports and a literature review

open access: yesBMC Infectious Diseases, 2021
Background Leptospirosis is a zoonotic illness caused by pathogenic spirochetes of the genus Leptospira. The disease spectrum ranges from a mild influenza-like presentation to a more serious Weil’s syndrome.
A. G. N. M. K. Bandara   +3 more
doaj   +1 more source

Real‐time fluorometric isothermal assays for detection of Streptococcus equi subspecies equi and Streptococcus equi subspecies zooepidemicus in horses: Validation, comparison and evaluation of their clinical application

open access: yesAustralian Veterinary Journal, EarlyView.
Infectious diseases significantly impact equine health and welfare, causing illness and death, and loss of productivity globally. One such disease is ‘strangles’, a highly contagious upper respiratory condition in horses caused by Streptococcus equi subspecies equi (SEE).
M Jelocnik   +11 more
wiley   +1 more source

Meningitis purulenta aséptica o meningitis que responde a corticoesteroides [PDF]

open access: yes, 1993
En esté trabajo presentamos el primer caso diagnosticado en nuestro Hospital de una meningitis purulenta aséptica, o meningitis que responde a corticosteroides.
Añor Torres, Sònia   +4 more
core  

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network [PDF]

open access: yes, 2013
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients.
A Bashey   +88 more
core   +4 more sources

Home - About - Disclaimer - Privacy